Cargando…
Publisher Correction: GLS-409, an Antagonist of Both P2Y(1) and P2Y(12), Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation
Autores principales: | Smolensky Koganov, Elena, Michelson, Alan D., Yanachkov, Ivan B., Yanachkova, Milka I., Wright, George E., Przyklenk, Karin, Frelinger, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265290/ https://www.ncbi.nlm.nih.gov/pubmed/30498241 http://dx.doi.org/10.1038/s41598-018-35956-6 |
Ejemplares similares
-
GLS-409, an Antagonist of Both P2Y(1) and P2Y(12), Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation
por: Smolensky Koganov, Elena, et al.
Publicado: (2018) -
Antiplatelet Activity, P2Y(1) and P2Y(12) Inhibition, and Metabolism in Plasma of Stereoisomers of Diadenosine 5′,5′″-P(1),P(4)-dithio-P(2),P(3)-chloromethylenetetraphosphate
por: Chang, Hung, et al.
Publicado: (2014) -
P2Y(12) Receptor Blockade Augments Glycoprotein IIb‐IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant Activity
por: Berny‐Lang, Michelle A., et al.
Publicado: (2013) -
Publisher Correction: Stereotactic Cortical Atlas of the Domestic Canine Brain
por: Johnson, Philippa J., et al.
Publicado: (2021) -
Publisher Correction: Initiation and propagation kinetics of inhibited lipid peroxidation
por: Farhoosh, Reza
Publicado: (2021)